Valuation CStone Pharmaceuticals OTC Markets

Stocks

Delayed OTC Markets Other stock markets 23:21:14 10/07/2026 +04			5-day change	1st Jan Change
0.7100 ^USD	+19.43%		+19.43%	-20.49%

06-26	CStone Pharma Taps Arrotex to Commercialize Sugemalimab in Australia, New Zealand	MT
06-25	CStone Pharmaceuticals Enters into Exclusive Commercialization Agreement with Arrotex Pharmaceuticals for Sugemalimab Across Australia and New Zealand	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	7,845	4,882	2,628	2,759	6,980	7,298	-	-
Change	-	-37.77%	-46.18%	4.99%	153.01%	4.55%	-	-
Enterprise Value (EV) ¹	7,249	4,551	1,950	2,404	6,404	6,770	3,695	3,121
Change	-	-37.22%	-57.15%	23.28%	166.37%	5.71%	-45.42%	-15.52%
P/E	-	-5.32x	-7.11x	-30.9x	-15.3x	-343x	6.82x	41.5x
PBR	6.63x	10.9x	5.7x	-	10.7x	-	-	-
PEG	-	-	0.1x	0.4x	-0x	3.6x	-0x	-0.5x
Capitalization / Revenue	32.2x	10.1x	5.67x	6.78x	25.9x	15.2x	4.26x	6.62x
EV / Revenue	29.7x	9.45x	4.2x	5.9x	23.8x	14.1x	2.16x	2.83x
EV / EBITDA	-3.99x	-5.1x	-3.33x	-25.9x	-16.5x	-16.5x	1.88x	4.31x
EV / EBIT	-3.96x	-4.99x	-3.22x	-22.7x	-14.8x	-17.7x	3.3x	17.6x
EV / FCF	-4.57x	-7.43x	-	-	-19.5x	3,385x	49.9x	44.6x
FCF Yield	-21.9%	-13.5%	-	-	-5.12%	0.03%	2%	2.24%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-	-0.77	-0.29	-0.07	-0.31	-0.0133	0.67	0.11
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	243.7	481.4	463.8	407.2	269.6	479.3	1,713	1,103
EBITDA ¹	-1,818	-892.9	-585.4	-92.72	-388.6	-409.6	1,962	724.4
EBIT ¹	-1,829	-912.1	-605.6	-106.1	-432.6	-383.2	1,118	177.6
Net income ¹	-1,920	-902.7	-367.2	-91.21	-437	-243.2	687.4	93.49
Net Debt ¹	-596.2	-331.1	-677.7	-354.7	-576.3	-528.2	-3,603	-4,177
Reference price ²	6.737	4.096	2.061	2.161	4.736	4.566	4.566	4.566
Nbr of stocks (in thousands)	1,164,452	1,192,099	1,275,317	1,276,503	1,473,942	1,598,209	-	-
Announcement Date	08/06/22	26/04/23	23/04/24	27/03/25	26/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	17.35x	3.77x	10.12x	0.59%	67.61B
UCB	25.62x	5.26x	15.43x	0.62%	51.6B
SAMSUNG BIOLOGICS CO.,LTD.	34.5x	11.72x	22.4x	-.--%	43B
CSL LIMITED	-46.01x	3.23x	9.56x	3.34%	40.94B
BIOGEN INC.	30.35x	3.47x	10.97x	-.--%	29.4B
MODERNA, INC.	-7.88x	11.31x	-6.94x	-.--%	27.09B
INCYTE CORPORATION	37.89x	3.25x	9.81x	-.--%	23.32B
INNOVENT BIOLOGICS, INC.	62.11x	6.31x	43.4x	-.--%	19.92B
SWEDISH ORPHAN BIOVITRUM AB	26.16x	5.4x	14.45x	-.--%	16.91B
Average	20.01x	5.97x	14.35x	0.5%	35.53B
Weighted average by Cap.	16.69x	5.83x	13.47x	0.65%